Spotify's acquisition last week of the music licensing start-up Loudr helps the streaming service to better manage its costs so that it can focus on attracting new subscribers for its premium service, said a digital media investment banker who helped Loudr close the deal.
Loudr's services are intended to make it easier for content creators and digital music services to identify, track, and pay royalties to music publishers more efficiently. Royalties are, of course, part of Spotify's recurring costs.
"It makes sense for Spotify, which is the largest music streaming service in terms of paid users, to take control of this important piece," said Sun Jen Yung, a partner and the head of digital media at Nfluence Partners.
Loudr makes the complex process of paying royalties easier through automation, she said Wednesday in an interview on Cheddar.
This week, Spotify announced it will update its mobile app soon in an effort to make it easier to use.
"To the extent that they can attract more users, that can hopefully help them upgrade to a premium service," said Yung.
For full interview, [click here](https://cheddar.com/videos/inside-spotifys-acquisition-of-loudr).
Conditions have been mostly nice for travelers flying ahead of and on Christmas Day, but some naughty disruptions plagued those flying with Southwest Airlines again this year.
Gift cards make great stocking stuffers — just as long as you don't stuff them in a drawer and forget about them after the holidays.
Big Business This Week is a guided tour through the biggest market stories of the week, from winning stocks to brutal dips to the facts and forecasts generating buzz on Wall Street.
Bristol Myers Squibb agreed to buy schizophrenia drug maker Karuna Therapeutics in a $14 billion deal.
Supermarket chain Ralphs is facing a new lawsuit from the state of California.
Shake Shack is giving out free fried chicken sandwiches, bacon cheese fries and milkshakes nationwide.
The IRS is announcing a voluntary disclosure program.
Lionsgate announced its studio division is going to spin off in a merger with Screaming Eagle Acquisition Corp., which is a special purpose acquisition company.
A new report suggests that it's getting more difficult for an average American to afford a home.
The Food and Drug Administration warned consumers about a copycat version of the diabetes drug Ozempic.
Load More